DNA Nanobots

Private

Powell, OhioHealthcare & Life Scienceshttps://dnananobots.com/

Last Round

Seed

Dec 17, 2025

Total Funding Raised

$3.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

DNA Nanobots is a biotechnology company that develops DNA nanotechnology-based solutions for biomedical applications, including targeted cancer drug delivery, vaccine development, and nucleic acid biosensing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

DNA origaminon-viral gene therapytargeted drug deliverynanomedicineDNA nanobotsgene delivery platformself-assembling nanostructuresCRISPR deliverytargeted chemotherapycancer vaccine deliverynucleic acid biosensingbiopharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DNA Nanobots Comps

Public and private peers based on sector, stage, and business model.

DNA Nanobots comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DNA Nanobots Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 17, 2025
Pre Seed	Jan 24, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Christopher Lucas

Co-Founder And Chief Science Officer

Founding Team

Patrick Halley

Co-Founder Chief Technology Officer

Founding Team

James F. Lynch

Chief Executive Officer

Executive Team

Jeff Spitzner

Founding CEO And Chief Strategist

Founding Team

View all key people

DNA Nanobots Investors

Notable investors and investment history

DNA Nanobots investors
Investor	Rounds
Ohio State Early Investor Network	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 16, 2026
Monthly visitors increased 52% MoM.
May 24, 2026
Grew 45% QoQ from 11 to 16 employees.

View all signals

DNA Nanobots Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DNA Nanobots Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DNA Nanobots's valuation, stock price, and market status.

Firmographic Details

HeadquartersPowell, Ohio

Employee Range16

Year Founded2021

Last FundingDec 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.